Dr. Ankur BAHL
- Name:Dr. Ankur BAHL
- Position:Oncology
- Experience: 15 years
Follow Us:
Dr. Ankur BAHL
Dr. Ankur Bahl is a highly esteemed Senior Director of Medical Oncology at Fortis Memorial Research Institute (FMRI), Gurugram, with over 15 years of expertise in cancer care. A distinguished oncologist, he has an exceptional academic background, having earned his MBBS and MD in Medicine from Maulana Azad Medical College, Delhi, followed by a DM in Medical Oncology from the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi.
Dedicated to continuous learning, Dr. Bahl further honed his expertise with specialized training in Adverse Drug Reactions, Drug Interactions, and Pharmacovigilance at the University of Oxford, UK. His clinical proficiency spans a wide spectrum of oncology treatments, including immunotherapy, targeted therapy combined with chemotherapy, hormonal therapy, and palliative care, ensuring comprehensive cancer management.
A pioneer in oncology research, Dr. Bahl has led groundbreaking studies, including the largest real-world Indian data on targeted therapy (Cetuximab) in Head & Neck cancer, advancements in Acute Myeloid Leukemia treatment, and Human Papillomavirus (HPV) trends in India. His vast experience includes key leadership roles, such as Director of Medical Oncology and Hematology Oncology at Max Hospital, Saket, and associations with renowned institutions like Rajiv Gandhi Cancer Institute and Maulana Azad Medical College.
Designation
SENIOR DIRECTOR MEDICAL ONCOLOGY | Fortis Gurgaon
Oncology | Oncology | Medical Oncology
Core Strengths
Work Experience
Senior Director Medical Oncology and Hemato-Oncology at Fortis Healthcare (present)
Director – Medical Oncology & Haematology Oncology at Max Healthcare, Saket, Delhi, India
Senior Consultant, Medical Oncology and Hemato Oncology at Max Super Speciality Hospital
Consultant, Medical Oncology and Hemato Oncology at Max Super Speciality Hospital
DM Medical Oncology at AIIMS, New Delhi, India
DNB Fellow, Department of Medical Oncology at Rajiv Gandhi Cancer Institute & Research Centre
Senior Resident, Department of Medicine at Maulana Azad Medical College
MD Medicine at Maulana Azad Medical College
Publications
A case of primary rectal non-Hodgkin’s lymphoma treated with chemotherapy. Singla R, Kumar P, Bahl A, Kumar S, Saran RK, Kar P. Trop Gastroenterol.
Acute onset flaccid quadriparesis in pediatric non-Hodgkin lymphoma: vincristine induced or Guillain-Barré syndrome? Bahl A, Chakrabarty B, Gulati S, Raju KN, Raja A, Bakhshi S. Pediatr Blood Cancer.
Autologous Stem Cell Transplantation for Multiple Myeloma: Identification of Prognostic Factors. Kumar L, Cyriac SL, Tejomurtula TV, Bahl A, Biswas B, Sahoo RK, Mukherjee A, Sharma O. Clin Lymphoma Myeloma Leuk.
Carcinoma esophagus: a rare primary malignancy for ocular metastasis. Pal D, Bahl A, Sharma JB, Rao RR. Indian J Cancer.
Dasatinib in chronic myeloid leukemia: A limited Indian experience. Sharma A, Bahl A, Raina V, Kumar L, Gupta R. Asia Pac J Clin Oncol.
Dengue Fever in patients with pediatric malignancy on chemotherapy: a concern in tropical countries. Bahl A, Bakhshi S. Pediatr Blood Cancer. 2011 Dec 15;57(7):1249-50.
Long-term outcomes for patients with acute myeloid leukemia: A single-center experience from AIIMS, India. Bahl A, Sharma A, Raina V, Kumar L, Bakhshi S, Gupta R, Kumar R. Asia Pac J Clin Oncol. 2015 Jan 30.
Metronomic Chemotherapy in Progressive Pediatric Malignancies: Old Drugs in New Package. Bahl A, Bakhshi S. Indian J Pediatr. 2012 Apr 28.
Occipital condyle syndrome as a rare metastatic presentation of small cell lung carcinoma. Bahl A, Suresh P, Talwar V, Doval DC. Neurol India. 2010 Jul-Aug;58(4):666-8.
Prevalence and trends of human papillomavirus in oropharyngeal cancer in a predominantly north Indian population. Bahl A, Kumar P, Dar L, Mohanti BK, Sharma A, Thakar A, Karthikeyan V, Sikka K, Singh C, Poo K, Lodha J. Head Neck.
Severe Eosinophilia in Metastatic Carcinoma Breast: A Rare Paraneoplastic Phenomenon. Ankur Bahl, Prashant Mehta, Vinod Raina. EJCMO 2011.
